Name: Mad Money 01/12/26 | Audio Only
Uploaded: 2026-01-13T01:02:04+00:00
Duration: 2659 s

Speakers

Jim Cramer — Host, Mad Money

Mike Gustar — President and CEO, Novo Nordisk

Geoff Martha — CEO, Medtronic

Albert Bourla — CEO, Pfizer

Brent Saunders — Chairman and CEO, Bausch + Lomb

Summary

Jim Cramer hosts a special Mad Money from the JPMorgan Healthcare Conference in San Francisco, interviewing Novo Nordisk, Medtronic, Pfizer, and Bausch + Lomb CEOs. The CEOs highlighted obesity pills, surgical robotics, cardiac ablation, renal denervation, pharma pipelines, dividends, and margin-improvement plans. Cramer also took calls, favoring Shopify, Prologis over CubeSmart, and calling Sony undervalued, while dismissing concerns about Powell prosecution and a credit-card rate cap.

Cramer believes markets are ignoring politically driven risks around Fed independence and credit-card rate caps.
Novo Nordisk CEO says oral Wegovy expands the GLP-1 market with lower pricing and CV benefits.
Medtronic CEO touts AI colonoscopy, Hugo robotics, PFA, and hypertension renal denervation.
Pfizer CEO says dividend is safe and outlines weight-loss, Seagen, and Nurtec pipeline catalysts.
Bausch + Lomb CEO highlights contact lens and glaucoma pipeline, margin targets, and M&A openness.
Lightning round: Cramer favors Shopify and Prologis, dislikes CubeSmart, calls Sony undervalued.

Ideas

Jim Cramer Host, Mad Money 4:04

Shopify is a buy on rally.

Cramer thinks the market is wrong to punish Shopify; he says the stock is a buy and that today's rally is the right move, expecting Shopify to go higher.

Mike Gustar President and CEO, Novo Nordisk 5:48

Oral Wegovy expands obesity market.

Gustar says the new oral Wegovy pill expands the GLP-1 market by removing injection phobia, taboo, and refrigeration barriers; it delivers the same 16.6% weight loss and cardiovascular benefits as the injectable at accessible prices ($149-$249, $25 with insurance), addressing a large untreated obesity population. He also highlights rare disease launches in sickle cell and hemophilia.

Geoff Martha CEO, Medtronic 17:18

Medtronic has multiple generational growth drivers.

Martha says Medtronic has multiple generational growth drivers: AI-assisted colonoscopy is becoming standard of care, Hugo is the first real competitive surgical robot to Intuitive with modularity and cost advantages, PFA cardiac ablation is growing 70% and boosting margins, Simplicity renal denervation has Medicare coverage for uncontrolled hypertension, and the diabetes spin-off sharpens focus. He expects these to accelerate revenue growth and earnings.

Geoff Martha CEO, Medtronic 17:18

Medtronic has multiple generational growth drivers.

Albert Bourla CEO, Pfizer 27:21

Pfizer dividend safe despite LOEs.

Borla says Pfizer is going all in on weight loss with 10 phase 3 studies and expects data for an ultra-long-acting monthly GLP-1; he also points to Seagen's new-generation lung cancer readout in a $60 billion market, Nurtec's expansion into menstrual and chronic migraine prevention, and new launches driving growth.

Jim Cramer Host, Mad Money 35:18

CubeSmart lacks growth; Prologis is better.

Cramer says CubeSmart does not have enough growth and there are better options; he prefers Prologis as the best play.

Jim Cramer Host, Mad Money 35:18

CubeSmart lacks growth; Prologis is better.

Cramer says CubeSmart does not have enough growth and there are better options; he prefers Prologis as the best play.

Jim Cramer Host, Mad Money 35:37

Sony is undervalued and a buy.

Cramer says Sony is down for the year but the stock is undervalued and is a buy.

Brent Saunders Chairman and CEO, Bausch + Lomb 37:25

Bausch + Lomb pipeline targets growth.

Saunders says Bausch + Lomb has its deepest pipeline in 172 years, including a bioactive contact lens that is the first major lens innovation in 25 years, a phase 2 glaucoma asset that improves vision, Lumify innovation, and dry eye/ocular pain products. The investor day plan targets fastest-growing eye care company with 600 basis points of margin improvement and he is confident in delivering the numbers.

Mad Money 01/12/26 | Audio Only

Summary

Ideas

Up Next